MA21.05 Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung CancerS. Watanabe,N. Matsumoto, J. Koshio,A. Ishida, T. Tanaka,T. Abe,D. Ishikawa,S. Shoji,K. Nozaki,K. Ichikawa,R. Kondo, A. Otsubo,A. Aoki, T. Kajiwara, K. Koyama,S. Miura,H. Yoshizawa,T. KikuchiJOURNAL OF THORACIC ONCOLOGY（2019）引用 4|浏览67暂无评分关键词alectinib,ALK,BevacizumabAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
